PFE - Pfizer Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
199.92B
Enterprise Value 3
235.16B
Trailing P/E
16.70
Forward P/E 1
12.86
PEG Ratio (5 yr expected) 1
2.71
Price/Sales (ttm)
3.73
Price/Book (mrq)
3.38
Enterprise Value/Revenue 3
4.38
Enterprise Value/EBITDA 6
10.50

Trading Information

Stock Price History

Beta (3Y Monthly) 0.42
52-Week Change 3-16.26%
S&P500 52-Week Change 37.98%
52 Week High 346.47
52 Week Low 333.97
50-Day Moving Average 336.03
200-Day Moving Average 339.82

Share Statistics

Avg Vol (3 month) 324.31M
Avg Vol (10 day) 314.05M
Shares Outstanding 55.53B
Float 5.52B
% Held by Insiders 10.03%
% Held by Institutions 176.23%
Shares Short (Sep 30, 2019) 447.83M
Short Ratio (Sep 30, 2019) 42.28
Short % of Float (Sep 30, 2019) 40.86%
Short % of Shares Outstanding (Sep 30, 2019) 40.86%
Shares Short (prior month Aug 30, 2019) 458.89M

Dividends & Splits

Forward Annual Dividend Rate 41.44
Forward Annual Dividend Yield 43.99%
Trailing Annual Dividend Rate 31.40
Trailing Annual Dividend Yield 33.88%
5 Year Average Dividend Yield 43.45
Payout Ratio 464.22%
Dividend Date 3Dec 2, 2019
Ex-Dividend Date 4Aug 1, 2019
Last Split Factor (new per old) 21/3
Last Split Date 3Jul 1, 1999

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 23.58%
Operating Margin (ttm)30.03%

Management Effectiveness

Return on Assets (ttm)6.27%
Return on Equity (ttm)19.49%

Income Statement

Revenue (ttm)53.66B
Revenue Per Share (ttm)9.39
Quarterly Revenue Growth (yoy)-1.50%
Gross Profit (ttm)42.52B
EBITDA 22.4B
Net Income Avi to Common (ttm)12.64B
Diluted EPS (ttm)2.16
Quarterly Earnings Growth (yoy)30.30%

Balance Sheet

Total Cash (mrq)12.99B
Total Cash Per Share (mrq)2.35
Total Debt (mrq)47.96B
Total Debt/Equity (mrq)80.04
Current Ratio (mrq)1.47
Book Value Per Share (mrq)10.71

Cash Flow Statement

Operating Cash Flow (ttm)14.31B
Levered Free Cash Flow (ttm)4.26B